Protalix BioTherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	70.84	52.74	53.4	65.49	47.64	38.35
Revenue Growth (YoY)	32.65%	-1.23%	-18.47%	37.48%	24.22%	-39.03%
Cost of Revenue	25.25	26.99	24.32	22.98	19.59	16.35
Gross Profit	45.59	25.75	29.08	42.51	28.05	22
Selling, General & Admin	12.11	11.68	12.19	14.96	11.71	12.73
Research & Development	19	19.57	12.97	17.09	29.35	29.73
Total Operating Expenses	31.11	31.25	25.16	32.05	41.06	42.46
Operating Income	14.47	-5.5	3.92	10.46	-13.01	-20.46
Interest Income	1.16	1.08	1.3	1.29	1.15	0.4
Interest Expense	-0.76	-1.19	-1.06	-3.18	-2.53	-7.52
Total Non-Operating Income (Expense)	0.4	-0.11	0.24	-1.89	-1.38	-7.12
Pretax Income	14.87	-5.61	4.15	8.57	-14.4	-27.58
Provision for Income Taxes	-1.33	1	1.22	0.25	0.53	-
Net Income	11.55	-6.6	2.93	8.31	-14.93	-27.58
Net Income to Common	11.55	-6.6	2.93	8.31	-14.93	-27.58
Net Income Growth	293.90%	-	-64.73%	-	-	-
Shares Outstanding (Basic)	79	79	73	68	48	44
Shares Outstanding (Diluted)	80	79	81	82	48	44
Shares Change (YoY)	-1.31%	-3.10%	-1.66%	70.04%	9.81%	51.43%
EPS (Basic)	0.14	-0.08	0.04	0.12	-0.31	-0.62
EPS (Diluted)	0.13	-0.08	0.04	0.09	-0.31	-0.62
EPS Growth	225.00%	-	-55.56%	-	-	-
Shares Outstanding	79.85	80.43	75.85	72.95	53.79	45.56
Free Cash Flow	-	-13.63	7.39	-2.47	-25.63	-11.74
Free Cash Flow Per Share	-	-0.17	0.09	-0.03	-0.53	-0.27
Gross Margin	64.35%	48.82%	54.46%	64.91%	58.87%	57.37%
Operating Margin	20.43%	-10.43%	7.34%	15.97%	-27.32%	-53.36%
Profit Margin	22.87%	-12.52%	5.49%	12.69%	-31.33%	-71.92%
FCF Margin	-	-25.84%	13.84%	-3.77%	-53.80%	-30.62%
EBITDA	14.47	-4.04	5.22	11.65	-11.93	-19.34
EBITDA Margin	20.43%	-7.65%	9.78%	17.79%	-25.04%	-50.44%
EBIT	14.47	-5.5	3.92	10.46	-13.01	-20.46
EBIT Margin	20.43%	-10.43%	7.34%	15.97%	-27.32%	-53.36%
Effective Tax Rate	-8.95%	-17.76%	29.42%	2.97%	-3.68%	0.00%

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q